Former Chief of Infectious Diseases & AIDS Medicine at the San Mateo Medical Center
Pro to the question "Should Marijuana Be a Medical Option?"
"[I]t is clear that there are people who use marijuana solely to ameliorate symptoms associated with chronic disease, such as HIV/AIDS. This suggests that cannabinoids have potential benefit as a therapeutic class of agents."
"Marijuana Improves Adherence to Anti-HIV Therapy," Reuters Health, February 12, 2005
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
President and CEO, Innovative Support to Emergencies Diseases and Disasters (InSTEDD), 2007-present
Former chief of Infectious Diseases & AIDS Medicine, Clinical Clinical Trials & Research, San Mateo Medical Center
Board of Directors, United States Doctors for Africa, Inc.
Former Medical Marijuana Researcher, Center for Medicinal Cannabis Research
Former Clinical Professor of Infectious Diseases, Stanford University School of Medicine
Former President and Executive Director, World Wide Aids Coalition
Former Medical Director, AIDS Empowerment and Treatment International, a nongovernmental organization
Former Medical Director, San Mateo County AIDS Program
MD, Albert Einstein College of Medicine, Yeshiva University, 1981
Cowritten with de Jong, B.C., Prentiss, D., McFarland, W., Machekano, R., "Marijuana Use and Its Association With Adherence to Antiretroviral Therapy Among Hiv-Infected Persons With Moderate To Severe Nausea," Journal of Acquired Immune Deficiency Syndrome, 2005
Cowritten with Vosvick M., Gore-Felton C., Ashton E., Koopman C., Fluery T., Spiegel D., "Sleep Disturbances Among HIV-positive Adults: The Role of Pain, Stress, and Social Support," Journal Psychosomatic Research, 2004
Cowritten with Wu T.D., Schiffer C.A., Gonzales M.J., Taylor J., Kantor R., Chou S., Zolopa A.R., Fessel W.J., Shafer R.W., "Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments," Journal of Virology, 2003
Cowritten with Gonzales M.J., Wu T.D., Taylor J., Belitskaya I., Kantor R., Chou S., Zolopa A.R., Fessel W.J., Shafer R.W., "Extended Spectrum of Hiv-1 Reverse Transcriptase Mutations in Patients Receiving Multiple Nucleoside Analog Inhibitors," AIDS, 2003
Cowritten with Kantor R., Fessel W.J., Zolopa A.R., Shulman N., Montoya J.G., Harbour M., Schapiro J.M., Shafer R.W., "Evolution of Primary Protease Inhibitor Resistance Mutations During Protease Inhibitor Salvage Therapy," Antimicrobrobial Agents and Chemotherapy, 2002